Fermentalg

Regulatory Filings • Jul 21, 2016

Press release

Activity in H1 2016

Libourne – 21 July 2016 – Fermentalg, an industrial biotechnology company that specializes in the production of oils and proteins derived from microalgae, has reported on activity during the first half of 2016.

En route towards the commercialization of DHA

The start to 2016 was marked by 2 major advances in the commercialization of DHA (Omega 3):

• the signing of an industrial agreement for the large-scale production of DHA with ARD, a company specializing in bio-refining, industrial biotechnologies and biobased chemistry;
• the completion of the DHA process book which is the last stage in preindustrialization at the company's scientific facilities in Libourne and opens the way for large-scale production.

With this in mind, Fermentalg has confirmed that it intends to launch this first product on the market between now and the end of the year.

Development milestones for the 4 other portfolio products

Alongside DHA, which is currently its most advanced product, Fermentalg has continued with the scientific and pre-industrial development work needed to launch 4 additional products between now and 2020 (DHA+, BM Bastille, Phycocyanine and Astaxanthin).

IDU construction calendar confirmed

Fermentalg also went ahead with the construction of its Industrial Development Unit (IDU) in Libourne (Gironde). So far, the building which is scheduled for delivery in the third quarter of 2016 has represented an investment of €6.2 million (out of a total estimated budget of €23 million). Commissioning, which is tied to the start of on-site production, is still planned for 2018.

€22.3 million in cash at end-June 2016

Revenues generated through partnerships amounted to €0.17 million in the first half of 2016 (compared with €0.7 million for the same period in 2015).

Thanks to its strict management, Fermentalg has the robust and healthy financial footing needed to execute its strategic roadmap. Gross cash stood at €22.3 million on 30 June 2016.

About Fermentalg

Fermentalg is an industrial biotechnology company that specializes in producing sustainable oils and proteins derived from the exceptional properties of microalgae. Based in Libourne (Gironde), the company is looking to market 5 products between now and 2020: DHA, DHA+, BM Bastille, Phycocyanine and Astaxanthin. Fermentalg shares are listed on Euronext in Paris (FR0011271600 - FALG). For more information, visit the Fermentalg website at: www.fermentalg.com.

Press Relations: Investor Relations:

ACTUS finance & communication Alexandra Prisa Tel: +33 (0)1 53 67 36 90 aprisa@actus.fr

ACTUS finance & communication Jérôme Fabreguettes-Leib Tel: +33 (0)1 53 67 36 78 jfl@actus.fr